Dan Koboldt blogs about WashU's recent kickoff party for its Cancer Genomics Initiative. The center's goal is to sequence 150 cancer genomes in one year. They'll be looking at AML some more — they published on AML genomes in Nature last fall and this month in the New England Journal of Medicine — as well as breast cancer, lung cancer, glioblastoma multiforme, and ovarian cancer. Koboldt adds that he's heard rumors that they'll also tackle rarer cancers such as multiple myeloma. "As Tim Ley said yesterday, it's thrilling to be a part of this. We truly are entering the golden age of cancer genomics," Koboldt blogs.
Aug 28, 2009